NCT06776198 Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study Status NOT_YET_RECRUITING Phase N/A
NCT06767007 SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer(SPARKLE) Status RECRUITING Phase PHASE2
NCT06758544 A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06731478 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer Status RECRUITING Phase PHASE3
NCT06728657 Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma Status SUSPENDED Phase PHASE2
NCT06727617 Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors Status RECRUITING Phase PHASE2
NCT06727357 Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06719700 Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT06718309 Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC Status RECRUITING Phase PHASE2
NCT06717178 Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China Status COMPLETED Phase N/A
NCT06709417 A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS) Status RECRUITING Phase PHASE2
NCT06699472 A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib Status RECRUITING Phase PHASE2
NCT06692166 A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer Status RECRUITING Phase PHASE3
NCT06691425 Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma Status RECRUITING Phase NA
NCT06686030 Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer Status RECRUITING Phase PHASE2
NCT06642441 Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer Status RECRUITING Phase NA
NCT06635980 Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer Status RECRUITING Phase PHASE2
NCT06610734 Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC) Status RECRUITING Phase PHASE2